PINK1-mediated mitophagy supports lung cancer initiation and limits the efficacy of KRAS -targeted therapy
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Together, our findings identify PINK1-dependent mitophagy as an early vulnerability in KRAS -driven lung cancer and provide a rationale for targeting mitophagy to improve the efficacy of KRAS -targeted therapies.
Appeared: Sunday, October 18. Science Advances. Peer-reviewed journal.